More scientists than ever are embracing mRNA technology for vaccine and therapeutic applications. However, the road to GMP manufacturing can be challenging for those new to the field. In this mRNA Basics webinar, Sawan Shah, Senior Business Development Manager at TriLink, will cover the key considerations for transitioning your mRNA program to GMP. A live Q&A session will follow the presentation.
Date: June 29, 2021 Time: 9am PDT / 12pm EDT / 5pm GMT/ 6pm CEST Title: Streamlined mRNA Synthesis with CleanCap® Technology
Featured Speaker:
Jordana Henderson, MS
Scientist, TriLink BioTechnologies
In this presentation, we will explore the manufacturing benefits of IVT synthesis using CleanCap Cap1 analogs for highly functional mRNA as shown in mice. Followed by live Q&As
Analytical testing is a key component of every mRNA therapeutic program. In this mRNA Basics webinar, Jessica Madigan, Director Business Development, GMP at TriLink, will discuss analytical testing considerations for mRNA and common mistakes to avoid. A live Q&A session will follow the presentation.
United States 
